RecruitingNCT06658093
RESTOR: PK/PD mTORi Inhibition in Older Adults
EARLY_PHASE1 · 194 planned enrolment
- Countries listed
- 1
- Registry update
- June 1, 2026
Registry Intervention View
everolimus
Trial registrations containing the exact intervention label everolimus.
Exact registry label · Not reported
8 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
3 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
RecruitingNCT05949658
Rapalog Pharmacology (RAP PAC) Study
PHASE1 · 72 planned enrolment
- Countries listed
- 1
- Registry update
- May 28, 2026
RecruitingNCT07191353
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
PHASE2 · 148 planned enrolment
- Countries listed
- 1
- Registry update
- April 6, 2026
CompletedNCT02338609
Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus
PHASE4 · 15 planned enrolment
- Countries listed
- 3
- Registry update
- August 9, 2024
CompletedNCT01154439
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
PHASE1 · 11 planned enrolment
- Countries listed
- 1
- Registry update
- October 26, 2022
CompletedNCT00789828
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
PHASE3 · 117 planned enrolment
- Countries listed
- 10
- Registry update
- February 3, 2016
UnknownNCT01631058
Renal Transplantation in the Elderly - nEverOld Study
PHASE4 · 90 planned enrolment
- Countries listed
- 1
- Registry update
- December 4, 2015
TerminatedNCT00857259
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
PHASE2 · 16 planned enrolment
- Countries listed
- 2
- Registry update
- August 19, 2011